Manipulating the Memory of T Cells for Immunotherapies
Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies
Boosting T cell memory may result in long-lasting and effective responses for patients treated with checkpoint blockade immunotherapies
CYC065, an inhibitor of CDK2 and CDK9 kinases, has inhibited tumor growth in some patients with advanced cancers
First human trials examine the impact of dark chocolate consumption on cognition and other brain functions
How a researcher at UC San Diego is elucidating the role of microglial dysfunction in brain trauma and disorders
Researchers aim to tackle the issue of plastic waste by enhancing pre-existing PETase – a known digestive enzyme for plastic materials
The highly anticipated platform was launched by Repositive at AACR annual meeting
Earlham Institute boosts national capability in genomics and single cell analysis with ultra-high throughput sequencing platform from Illumina
New Synapsys microbiology informatics solution will be demonstrated at the event
Learn the impact of column technology design on protein RPLC
Cell picking and imaging system by Yamaha has expanded applicability, including ex vivo tissue picking
During the American Association for Cancer Research 2018 Annual Meeting, SelectScience recognized cutting-edge products and technologies advancing life sciences research
The trial demonstrates that first-line pembrolizumab treatment improved overall and progression-free survival rates in patients with metastatic nonsquamous non-small cell lung cancer
The primary endpoint for first-line nivolumab-ipilimumab combo trial indicates improved progression-free survival in patients with advanced non-small cell lung cancer
Expansion of circulating tumor-specific T cells after nivolumab treatment suggests systemic antitumor immunity in patients with resectable lung cancer
The FT819 CAR T cell line has the potential to be mass-produced, stored, and made readily available for cancer immunotherapy